Karius Collects $50M For Disease Detection
Redwood City-based Karius, a developer of DNA-based infectious disease testing technology, announced on Monday that it has raised $50M in a Series A funding round. The funding was led by Data Collective and Lightspeed Venture Partners, and also included Tencent, Khosla Ventures, Innovation Endeavors, and Spectrum 28. Karius, led by CEo Mickey Kertesz, uses a standard blood draw and identifies DNA fragments left by bacteria, viruses, fungi, and other eukaryotic pathogens in a patient’s bloodstream.
posted on Tuesday, August 8, 2017
Related stories:
> Singulex Raises $19.1M
> Verge Genomics Gets $4M
> Krux Digital Collects $11M
> 23andMe Targets Parkinson's
> MyoKardia Gets $38M For Heart Disease Treatment
silicontap.com Home